Introduction
============

Gout is a disease caused by the deposition of monossodium urate (MSU) crystals in the joint and is characterized by swelling, redness, and intense pain. The prevalence and incidence of gout are increasing in both developed and developing countries ([@B33]). Acute gouty inflammation is initiated by recognition of MSU crystals by resident cells that produce pro-inflammatory mediators, especially IL-1β that is released by activation of the Nucleotide-bindingdomain Leucine-Rich-containing family Pyrin domain-containing-3 (NLRP3) inflammasome ([@B22]). IL-1β has a critical role in orchestrating the inflammatory reaction in response to MSU crystals and drives the production of chemokines and neutrophil influx into the joint ([@B2]). Neutrophils are the main inflammatory cells recruited to the joint and contribute to the amplification of the inflammatory reaction, pain and progressive tissue damage ([@B4]). After migration, the lifespan of neutrophils is significantly extended under inflammatory conditions ([@B19]). Eventually, they undergo apoptosis and induce clearance by phagocytic macrophages in a process termed efferocytosis. Neutrophil apoptosis and subsequent efferocyosis constitute an important step in the resolution of inflammation and restoration of steady state ([@B32]).

Resolution of inflammation, for many years, was considered a passive response, which was associated with the clearance of inflammatory stimulus, reduction of pro-inflammatory mediators and prevention of leukocyte recruitment. Resolution of inflammation is now considered an active process that involves synthesis of pro-resolving mediators that actively orchestrate the end of inflammation. In this context, the cardinal signs of resolution involves not only limitation of leukocyte migration and down regulation of chemokines and cytokines, but also the turning off of signaling pathways associated with leukocyte survival, which will eventually lead to leukocyte apoptosis and its subsequent efferocytosis ([@B35]).

Phosphoinositide 3- kinase (PI3K) is a key regulator in signaling pathways triggered by a large numbers of receptors on the neutrophil surface ([@B17]). PI3Ks are enzymes that catalyze the phosphorylation of inositol phospholipidis in the third position of the inositol ring resulting in the formation of phosphatidylinositol-3-phosphate \[PI(3)P\], phosphatidylinositol 3,4-biphosphate \[PI(3,4)P2\], and phosphatidylinositol 3,4,5-trisphosphate \[PI(3,4,5)P3\], collectively termed 3′-PI lipids. There are three classes of PI3K: Class I isoforms: class IA (p110α, P110β, P110δ) and IB (PI3Kγ), Class II isoforms (PI3KC2α, β, and γ) and Class III a single isoform ([@B16]). Isoforms PI3Kδ and PI3Kγ, from class I, are highly expressed in neutrophils suggesting that they have a particular role in these cells. PI3Ks are involved in neutrophil chemotaxis and it is also required for survival signals ([@B17]). Indeed, previous studies with non-isoform selective inhibitors -- eg., Wortmaninn and LY294002 - have shown that blockade of PI3Ks is associated with induction of the resolution of inflammation in various models of inflammation ([@B25]; [@B34]).

In the current study, we investigated the effect of delayed inhibition of PI3Kγ or PI3Kδ, the major isoforms expressed in neutrophils, in a model of gout in mice. Our results show that blockade of PI3Ks induces resolution of inflammation by increasing neutrophil apoptosis and eferocytosis. Of interest, blockade of all PI3Ks or either PI3Kγ or PI3Kδ resulted in similar degree of inhibition suggesting that function of both PI3Kγ or PI3Kδ is necessary to guarantee neutrophil survival *in vivo*.

Materials and Methods {#s1}
=====================

Mice
----

Male C57Bl/6 were obtained from the Center of bioterism of Universidade Federal de Minas Gerais (UFMG) Brazil. All mice were supplied with water and food *ad libitum*. Mice were maintained in pathogen free conditions. This study was carried out in accordance with the recommendations of the law n° 11.794 from National Council for Control of Animals Experimentation -- CONCEA, Brazil. The protocol was approved by the Animal Ethics Council -- CEUA -- at Universidade Federal de Minas Gerais (protocol 2/2015). The total number of animals used in the current study was 130, distributed in experiments evaluating inhibition by selective PI3K inhibitor, for calculation of resolution indices, for histology, functional analysis (pain) and efferocytosis, as indicated in each relevant section of the manuscript.

MSU Induced Gout
----------------

Crystals of MSU was prepared from uric acid (Sigma-Aldrich - St. Louis MO, United States) as previously described ([@B2]). Mice under anesthesia (80:15 mg/kg ketamine:xylazine; i.p., Syntec, São Paulo, Brazil) were injected into the tibiofemoral knee joint with 100 μg of MSU crystals. The selective PI3K-γ inhibitor (AS605240 -- Echelor), the selective PI3K-δ inhibitor \[GSK045, ([@B15]; [@B18]), kindly donated by GlaxoSmithKline - GSK\], the PI3Kγ/δ inhibitor \[CL27c, a pan-PI3K Inhibitor -- ([@B26])\] or vehicle were given locally (intraarticular injection) at 12 h after the injection of MSU crystals (see Figure [1](#F1){ref-type="fig"}). Inflammatory parameters were evaluated at different time points after treatment, as indicated in each figure legend. Mice were euthanized and the knee cavity washed with PBS/BSA 3% (2 × 5 μL) to collect the cells. The total number of leukocytes were determined using the newbauer chamber after staining with Turk's solution. The differential counts were performed using standard morphologic criteria on a slide stained with May-Grunwald-Giemsa. Periarticular tissues were collected from the joints for evaluation of cytokines and myeloreproxidase (MPO) activity.

![Dose response of PI3K-γ inhibitor in a MSU--induced gout inflammation. Mice were injected with MSU crystals (100 μg) into the tibiofemoral joint and the treatment with different doses of PI3K-γ inhibitor was made locally, 12 h after MSU injection. Cells were harvested from the articular cavity at 18 h after MSU injection. The number of total leukocytes **(A)** neutrophil **(B)**, and mononuclear cell **(C)** were evaluated. Results are expressed as the number of leukocytes per cavity and are shown as the mean ± SEM of five mice in each group from one experiment representative of two independent experiments. Significance was calculated using ANOVA followed by Holm-Sidak's multiple comparison test. The exactly *p*-value are shown in the figure.](fphar-09-01505-g001){#F1}

Cytokines and Myeloperoxidase (MPO) Activity
--------------------------------------------

Periarticular tissue was collected and homogenized in PBS containing anti-proteases, as previously described ([@B2]). The concentration of IL-1β, CXCL1, TNF-α, and IL-10 was measured by ELISA assay in the supernatant of the homogenates and according to the instructions of the manufacturer (R&D systems). Results are expressed in pg/ml.

The myeloperoxidase activity assay was performed as previously described ([@B2]). Briefly, the pellet from samples homogenized for cytokines measurements, were homogenized with 0.05M NaH~2~PO~4~ containing 0.5% of hexadecyltrimethyl-ammoniumbromide (HETAB; Signa-Aldrich). Samples were frozen 3 times in liquid nitrogen and centrifuged to collect the supernatant for MPO assay. The assay used 3,3′, 5,5′-tetramethylbenzidine (TMB; Sigma-Aldrich) and was quantified at 450 nm in a spectrophotometer. Results are expressed as absorbance.

Evaluation of Hypernociception
------------------------------

The mechanical hypernociception were evaluated as previously described ([@B1]) using an electronic pressure-meter (Insight instruments, Ribeirão Preto, SP, Brazil). The dorsiflexion-elicited withdrawal threshold was expressed in grams (g) and used to infer behavioral responses associated with experimental pain (hypernociception).

Calculation of Resolution Indices
---------------------------------

The resolution indices were quantified as previously described ([@B12]). Briefly, cells were recovered from the knee lavage at 12, 18, 24, and 36 h after MSU challenge. The total cell count was determined using a Newbauer chamber and differential leukocyte counts using standard morphologic criteria on a slide stained with May-Grunwald-Giemsa. The Resolution interval (R*i*) was quantified by local kinetic of neutrophils infiltration defining the time interval between T*~max~* (peak of the infiltration) and T*~50~* (time when numbers of neutrophils drops to half of the peak).

Histological Analysis
---------------------

Samples were processed as previously described ([@B28]). Briefly, knee joints were collected, fixed in 10% formol and decalcified for 30 days in 14% EDTA. Tissues were included in paraffin, sectioned (5 μm) and stained with H&E. Two sections of knee joints were examined and scored by a pathologist (CQ-J) who was unaware of the experimental groups. The parameters evaluated were: severity of synovial hyperplasia, intensity and extension of inflammatory infiltrate, vascular hyperemia, presence of inflammatory cells in the synovial cavity and changes in tissue architecture. These criteria ranged from 0 to 8 points and the sum was used to obtain a histological score.

Western Blot Analysis
---------------------

Synovial tissue samples (20--40 mg tissue) were homogenized using a cell lysis buffer, as described ([@B12]). Protein amounts were quantified with the Bradford assay reagent from Bio-Rad (Hercules, CA, United States). Extracts (40 μg) were separated by electrophoresis on a denaturing, 10% polyacrylamide-SDS gel and electrotransferred to nitrocellulose membranes. Membranes was incubated with specific primary antibodies (anti-IκBα -- Cell Signaling) and then incubated with appropriated HRP-conjugated secondary antibody. Immunoreactive bands were visualized by using an ECL detection system, as described by the manufacturer (GE Healthcare, Piscataway, NJ, United States). For loading control, membranes were reprobed with anti-GAPDH (Sigma).

Assessment of Apoptosis and Efferocytosis
-----------------------------------------

Apoptosis and efferocytosis were assessed by flow cytometry, as described previously ([@B7]). Mice were injected with MSU crystals and 12 h later they were treated locally with PI3K inhibitors. For the apoptosis assays, the lavage of the knee was performed 4 h after the treatment with drugs. Cells were surface-stained for 30 min with anti-LY6G-BV421 antibody (eBioscience) and then labeled with annexin-V FITC and PI, as an index of loss of nuclear membrane integrity (PE Annexin V Apoptosis Detection Kit; BD PharmingenTM; United States). For the efferocytosis assays, joint wasy was performed 6 h after the treatment with PI3K inhibitors and cells were surface-stained for 30 min with anti-F4/80-PECy7 antibody (eBioscience). Then, cells were fixed for 10 min, treated with 1× permeabilization wash (Cytofix/Cytoperm Kit; BD Biosciences) and intracellularly stained with anti-Ly6G-BV421 antibody. Macrophage efferocytosis was assessed as a frequency of macrophages containing neutrophils (F4/80+ Ly6G+ cells).

Statistical Analysis
--------------------

The number of animals used in this study were determined by using a statistical software (GPOWER 3.1.9.2) during the preparation of the study design, considering the variation of numbers of neutrophils in the knee lavage in our previous publications. All results are presented as the mean ± SEM. The analysis of the difference between two groups was performed by two-tailed unpaired Student's T test. Normalized data were analyzed by one-way ANOVA, and differences between groups were assessed using the Holm-Sidak's multiple comparison *post hoc* test. A *p*-value \< 0.05 was considered significant. Calculations were performed using the Prism 7.0 software program for Windows (GraphPad software, San Diego, CA, United States).

Results
=======

PI3K-γ Inhibitor Reverses Neutrophils Recruitment in a Dose-Dependent Manner
----------------------------------------------------------------------------

As previously reported, MSU crystals induced influx of leukocytes, mainly neutrophils, into the knee joint at 18 h after injection. The treatment with a specific PI3K-γ inhibitor, AS605240, at the peak of the inflammation (i.e., 12 h after administration of MSU crystals) was efficient to reduce the number of accumulated neutrophils in a dose dependent manner (Figure [1B](#F1){ref-type="fig"}). The highest dose caused the greatest reduction of the number of neutrophils in the cavity and was used for further experiments. No difference was observed in the number of infiltrating mononuclear cells (Figure [1C](#F1){ref-type="fig"}).

Delayed Inhibition of PI3K-γ or PI3K-δ Induce Timely Resolution of Neutrophilic Inflammation
--------------------------------------------------------------------------------------------

To determine the effects of the drugs on the kinetics of neutrophil infiltration, we calculated the resolution indices (R*i*) after drug treatment. AS605240 or GSK045, a PI3K-δ inhibitor, were injected intraarticular at the peak of acute inflammation (i.e., 12 h) and cells from the synovial cavity harvested 6, 12, and 24 h after the drugs were given. The treatment with AS605240 or GSK045 shortened the resolution interval by ∼5h. These resolution indices R*i*: R*i*~MSU~: ∼9 h; R*i*~MSU+AS605240~: ∼4 h; R*i*~MSU+GSK045~: ∼4 h (Figure [2A](#F2){ref-type="fig"}) suggests an acceleration in the resolution of acute inflammation. At 18 h after injection of MSU crystals (6 h after injection of PI3K inhibitors), there was significant reduction of the number of total leukocytes (Figure [2B](#F2){ref-type="fig"}) and this reduction was due to inhibition of neutrophils (Figure [2C](#F2){ref-type="fig"}), but not mononuclear cells (Figure [2D](#F2){ref-type="fig"}). Overall, treatment with either AS605240 or GSK045 resulted in similar degree of inhibition of the parameters observed.

![Delayed treatment of PI3K-γ or PI3K-δ inhibitor in a MSU--induced gout inflammation induce timely resolution. Mice were injected with MSU crystals (100 μg) into the tibiofemoral joint and the treatment with intraarticular injection (i.a.,) of 50 μM of PI3K-γ or PI3K-δ inhibitor, 12 h after MSU injection. Cells were harvested from the articular cavity at 18, 24, and 36 h after MSU injection. The number of neutrophils and resolution indices were quantified **(A)**. Of note: ψ~max~ = maximal number of neutrophils, ψ~50~ = 50% of the maximum number of neutrophils, T~max~ = 12 h, the time point when neutrophil numbers reach maximum; T~50~ MSU+AS605240 and MSU+GSK045 group ∼ 16 h, the time point when PMN numbers reduce to 50% of maximum; and resolution interval R~i~ MSU+AS605240 and MSU+GSK045 group ∼ 4 h, the time period when 50% PMN are lost from the articular cavity. Leukocytes counts 18 h after MSU injection **(B)** total leukocytes numbers, **(C)** neutrophils, **(D)** mononuclear cells. Results are expressed as the number of leukocytes per cavity and are shown as the mean ± SEM of five mice in each group from one experiment representative of two independent experiments. Significance was calculated using ANOVA followed by Holm-Sidak's multiple comparison test. The exactly *p*-value are shown in the figure. ^\#\#^means *p* value \< 0.01 compared with 18 h MSU injected.](fphar-09-01505-g002){#F2}

Inhibition of PI3K-γ or PI3K-δ Reduced Neutrophil Accumulation and Cytokines That Mediates Joint Inflammation
-------------------------------------------------------------------------------------------------------------

To evaluate the inflammatory response after inhibition of different PI3K isoforms, we investigated the accumulation of neutrophils and production of pro-inflammatory cytokines in the periarticular tissue of mice 18 h after injection of MSU crystals. Both treatments reduced to a similar extent the accumulation of neutrophils in periarticular tissues, as assessed by measuring MPO activity (Figure [3A](#F3){ref-type="fig"}). Injection of MSU crystals induced an increase in levels of the pro-inflammatory mediators IL-1β, CXCL1, and TNF-α in periarticular tissue. Overall, the treatment with the PI3K-γ or PI3K-δ inhibitors caused a reduction of levels of pro-inflammatory mediators but the effects of the PI3K-γ inhibitor was more prominent than that of the PI3K-δ inhibitor (Figures [3B](#F3){ref-type="fig"}--[D](#F3){ref-type="fig"}).

![Effects of PI3K-γ or PI3K-δ inhibition on neutrophil accumulation and pro-inflammatory mediators production. Myeloperoxidase activity in homogenized periarticular tissue **(A)**. IL-1β levels **(B)**, CXCL1 **(C)**, and TNF-α levels **(D)**. Levels was measured by ELISA in supernatant of homogenized periarticular tissue. Results are expressed as the number of leukocytes per cavity and are shown as the mean ± SEM of five mice in each group from one experiment representative of two independent experiments. Significance was calculated using ANOVA followed by Holm-Sidak's multiple comparison test. The exactly *p*-value are shown in the figure.](fphar-09-01505-g003){#F3}

Inhibition of PI3K-γ or PI3K-δ Ameliorated Tissue Damage and Mechanical Hypernociception
----------------------------------------------------------------------------------------

After having demonstrated the pro-resolving properties of PI3K-γ or PI3K-δ inhibition, we turned our attention to the possible impact of treatment on tissue damage. Histological analysis of knees subjected to intraarticular injection of MSU crystals showed moderate infiltration of leukocytes, focal hyperplasia, and leukocytes in the synovial space 18 h after MSU crystal injection. Inhibition of PI3K-γ or PI3K-δ decreased all the observed parameters (Figure [4A](#F4){ref-type="fig"}) and resulted in overall decrease of the histopathological score (Figure [4B](#F4){ref-type="fig"}).

![Effects of delayed treatment of PI3K-γ or PI3K-δ inhibitor on tissue damage and hypernociceptive responses. Representative photographs of H&E-stained sections of knee from mice control (PBS), MSU challenge (MSU), mice challenge with MSU and post treated (12 h) with AS605240 (MSU+AS) and mice challenge with MSU and post treated (12 h) with GSK045 (MSU+GSK045) (bars represent 400 μm in magnification of 40× and 50 μm in magnification of 400×) **(A)**. Graph shown histological score of joint injury of MSU crystal injected mice **(B)**. Mechanical hypernociception was evaluated by an electronic pressure-meter 18 h after the injection of MSU crystals (100 μg; ia) treated or not with AS605240 or GSK045 (γ or δ -- 50 μM i.a.) **(C)**. Results are expressed as the number of leukocytes per cavity and are shown as the mean ± SEM of five mice in each group from one experiment representative of two independent experiments. Significance was calculated using ANOVA followed by Holm-Sidak's multiple comparison test. The exactly *p*-value are shown in the figure.](fphar-09-01505-g004){#F4}

Injection of MSU crystals induces mechanical hypernociception, an index of joint dysfunction, as measured by decrease in paw withdrawal threshold. The intraarticular injection of the PI3K-γ or PI3K-δ inhibitors reduced to a similar extent the hypernociception induced by the injection of MSU crystals (Figure [4C](#F4){ref-type="fig"}).

Mechanistically, the Inhibition of PI3K-γ or PI3K-δ Induced Neutrophils Apoptosis and Efferocytosis
---------------------------------------------------------------------------------------------------

Next, we investigated whether induction of neutrophil apoptosis and subsequent efferocytosis could account for the resolution of MSU crystal-induced inflammation. For this purpose, mice were treated intraarticularly with inhibitors at the peak of inflammation and cells harvested from the knee cavity 4 h after the treatment to evaluate apoptosis and 6 h after the treatment to evaluate efferocytosis. We observed that treatment with either inhibitor increased neutrophil apoptosis and efferocytosis to a similar extent (Figures [5A,B](#F5){ref-type="fig"}). Noteworthy, these events were associated with reduction in phosphorylation of IκBα, an important regulator of the pro-survival molecule NFκB (Figure [5C](#F5){ref-type="fig"}) (Original western blot Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). Taken together, ours results clearly suggest that inhibition of PI3K isoforms γ or δ accelerate apoptosis and efferocytosis through down-modulation of NFκB leading to resolution of inflammation.

![Effect of PI3K-γ inhibition or PI3K-δ inhibition on neutrophil apoptosis and efferocytosis in MSU-induced inflammation. Mice were injected with MSU crystals (100 μg) into the tibiofemoral joint and 12 h later received an injection of AS605240 or GSK045 (50 μM, i.a.). Four hours after treatment, the cells were collected to annexin V analysis **(A)**. Efferocytosis was evaluated in mice injected with MSU crystals (100 μg) into the tibiofemoral joint and 12 h later received an injection of AS605240 or GSK045. Knee was washed 18 h MSU injection and cells were surface-stained with anti-F4/80 for macrophages and then intracellularly stained with anti-Ly6G for neutrophils **(B)**. Results are expressed as the number of leukocytes per cavity and are shown as the mean ± SEM of five mice in each group from one experiment representative of two independent experiments. Significance was calculated using ANOVA followed by Holm-Sidak's multiple comparison test. The exactly *p*-value are shown in the figure. **(C)** Expression of p-IκBα by Western Blot in synovial tissue collected 18 h after MSU injection. For loading control, membrane was reprobed with anti-GAPDH.](fphar-09-01505-g005){#F5}

Pan-PI3K Inhibition Produced the Same Effects of Isolated Inhibition
--------------------------------------------------------------------

A pan-PI3K inhibitor, CL27c, was used to investigate whether inhibition of both PI3K isoforms could cooperate to achieve greater induction of resolution of inflammation. The pan-PI3K inhibition shortened the resolution interval by ∼5h, a result similar to that achieved by inhibiting either enzyme alone (Figure [6A](#F6){ref-type="fig"}). Noteworthy, the pan-PI3K inhibitor also induced apoptosis and subsequent efferocytosis of neutrophils recruited to the cavity (Figures [6B,C](#F6){ref-type="fig"}). Again, these effects were similar in magnitude to those observed with treatment with either PI3K inhibitor applied alone.

![Effect of pan-PI3K inhibition on neutrophil recruitment, apoptosis and efferocytosis in MSU-induced inflammation. Mice were injected with MSU crystals (100 μg) into the tibiofemoral joint and the treatment with intraarticular injection (i.a.) of 50 μM of pan-PI3K inhibitor, 12 h after MSU injection. Cells were harvested from the articular cavity at 18, 24, and 36 h after MSU injection. The number of neutrophils and resolution indices were quantified (A). Of note: ψ~max~ = maximal number of neutrophils, ψ~50~ = 50% of the maximum number of neutrophils, T~max~ = 12 h, the time point when neutrophil numbers reach maximum; T~50~ MSU+pan-PI3K inhibitor group ∼ 16 h, the time point when PMN numbers reduce to 50% of maximum; and resolution interval R~i~ MSU+pan-PI3K inhibitor group (γ/δ) ∼ 4 h, the time period when 50% PMN are lost from the articular cavity. **(A)** Apoptosis assay was evaluated 4 h after treatment, the cells were collected to annexin V analysis **(B)**. Efferocytosis was evaluated in mice injected with MSU crystals (100 μg) into the tibiofemoral joint and 12 h later received an injection of pan-PI3K inhibitor. Cells were collected 18 h after MSU crystal injection and surface-stained with anti-F4/80 for macrophages and then intracellularly stained with anti-Ly6G for neutrophils **(C)**. Results are shown as the mean ± SEM of five mice in each group and are from one experiment representative of two independent experiments. Significance was calculated in relation to the control group (two-tailed unpaired Student's *t*-test). The exactly *p*-value are shown in the figure. ^\#\#^means *p* value \< 0.01 compared with 18 h MSU injected.](fphar-09-01505-g006){#F6}

Discussion
==========

The major findings of the current study were: (i) delayed inhibition of either PI3K-γ or PI3K-δ led to reduction of the accumulation of neutrophils in the joint cavity in response to the injection of MSU crystals. Reduction of neutrophil numbers was associated with reduction in the levels of pro-inflammatory mediators, decreased hypernociception and of tissue damage induced by MSU crystals. (iii) The beneficial effects of the delayed treatment with either inhibitor was secondary to their ability to cause resolution of inflammation, as seen by the induction of neutrophil apoptosis, their subsequent eferocytosis and faster restoration of steady state in the cavity ([@B22]). Inhibition of either PI3K isoform was sufficient to attain full inhibition of most inflammatory parameters. Indeed, there was no additional resolution of inflammation when a pan-PI3K inhibitor was used.

Inhibition of phosphatidylinositol 3-kinases (PI3Ks) have been shown to inhibit the recruitment of neutrophils in various models of inflammation ([@B13]). For example, blockade of PI3K-γ using AS605240 supressed joint inflammation and damage in a murine model of rheumatoid arthritis ([@B5]). Similarly, pharmacological blockade of PI3K-δ in K/BxN serum transfer model of arthritis reduced the overall extent of inflammation ([@B29]). We have shown that inhibition of both PI3K-γ and PI3K-δ was necessary for prevention of the recruitment of neutrophils *in vivo*, showing these enzymes played a redundant role in CXCL1-mediated neutrophil influx ([@B24]). Other studies have shown that non-selective inhibition of PI3K isoforms induced resolution of inflammation ([@B25]; [@B34]). Different from anti-inflammatory therapies that control inflammation by blocking key pro-inflammatory mediators that are expressed in the initial phase of the inflammation, pro-resolving therapies involve modifying the course of an established inflammation by reducing the time and accelerating the resolution ([@B31]; [@B11]). Here, we show for the first time that delayed treatment with selective inhibitors for PI3K-γ or PI3K-δ affected the resolution of inflammation, by reducing the time necessary to decrease 50% of neutrophil from the maximal number, demonstrating the potential pro-resolving properties of selective PI3K inhibition.

Inhibition of class Ia PI3K, with non-selective inhibitors, potentially downregulate cytokines generation in neutrophils ([@B10]). The interaction of MSU crystals with neutrophil leads to activation of class Ia PI3K that is involved in neutrophil degranulation ([@B27]). In gout, neutrophils are largely responsible for tissue damage caused by excessive release of granules into the synovial fluid ([@B6]). In addition to tissue damage, pain experienced by gouty patients during acute gout attack are the single most common reasons for these patients to seek medical care ([@B30]). Mechanical hypernociceptive response, an index of inflammatory pain, is associated with high number of neutrophils and increased levels of IL-1β ([@B2]; [@B12]). Here, treatment with inhibitors of either isoforms was sufficient to reduce the secretion of pro-inflammatory cytokines, and this was associated with reduced number of neutrophils in the periarticular tissue (MPO), reduced tissue damage and pain associated with MSU crystal-induced inflammation.

Previous studies have shown that non-selective PI3K inhibitors induced resolution of inflammation by increasing apoptosis of eosinophils ([@B25]; [@B34]) and neutrophils ([@B21]) in sites of inflammation induced by various stimuli. The clearance of apoptotic granulocytes is mostly mediated by efferocytosis in inflamed tissue ([@B14]). Here, we clearly show that selective blockade of PI3K-γ or PI3K-δ was sufficient to induce effectively apoptosis of neutrophils and induced their subsequent efferocytosis in a murine model of gout. Together with the reduction in resolution intervals, our results clearly show that inhibition of either enzyme will induce resolution of inflammation, suggesting that neutrophils may use PI3K-γ or PI3K-δ to remain at sites of inflammation *in vivo*.

Induction of the resolution of inflammation by treatment with a pan-PI3K inhibitor was similar in magnitude to that attained with either PI3K-γ or PI3K-δ inhibition separately. These results concur with the idea that neutrophils can use either PI3K-γ or PI3K-δ to remain at sites of inflammation. NF-κB appears to be a major transcription factor involved in the persistence of neutrophils at sites of inflammation ([@B23]; [@B20]). Indeed, we have shown that blockade of NF-κB resolve inflammation in various models of inflammation ([@B36], [@B37]; [@B3]), including in a model of gout ([@B38]). Other studies have shown that lipoxin A4 may modulate neutrophil infiltration by reducing the activation of NF-κB ([@B8], [@B9]). Importantly, non-selective inhibition of PI3K decreased NF-κB p65 translocation to the nucleus, suggesting that NF-κB is downstream of PI3K ([@B21]). Our results clearly show that inhibition of either PI3K-γ or PI3K-δ reduced activation of NF-κB in synovial tissues. Therefore, it appears that a major mechanism by which inhibition of PI3K controls neutrophil persistence in tissues is via control of NF-κB activation.

Taken together, our results show that inhibition of PI3K-γ or PI3K-δ isoforms induce resolution of inflammation in a murine model of gout. There was characterized by neutrophil apoptosis and increased efferocytosis and consequent reduction of pro-inflammatory mediators, hypernociception and tissue damage. It is unclear why both PI3K-γ and PI3K-δ are necessary to maintain neutrophil survival in the cavity; i.e., Blockade of either enzyme is sufficient to attain faster resolution of inflammation. Moreover, it is unclear whether blockade of these enzymes will translate into resolution of inflammation in more complex and chronic models of inflammation. Regardless of limitation, our results clearly show that PI3K-γ or PI3K-δ are needed to maintain neutrophil persistence in inflammatory infiltrates.
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